ROZZINI, Luca
 Distribuzione geografica
Continente #
NA - Nord America 5.808
EU - Europa 2.584
AS - Asia 1.254
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 6
OC - Oceania 5
Totale 9.672
Nazione #
US - Stati Uniti d'America 5.785
UA - Ucraina 832
CN - Cina 827
PL - Polonia 505
DE - Germania 350
IT - Italia 290
HK - Hong Kong 205
FI - Finlandia 174
GB - Regno Unito 122
IE - Irlanda 118
SG - Singapore 115
FR - Francia 104
IN - India 47
RU - Federazione Russa 22
VN - Vietnam 22
BE - Belgio 19
IR - Iran 16
CA - Canada 14
SE - Svezia 14
TR - Turchia 9
MX - Messico 8
CZ - Repubblica Ceca 7
EU - Europa 7
AU - Australia 5
JP - Giappone 5
AT - Austria 4
NL - Olanda 4
CH - Svizzera 3
ES - Italia 3
MU - Mauritius 3
BR - Brasile 2
BY - Bielorussia 2
CL - Cile 2
KR - Corea 2
LV - Lettonia 2
MY - Malesia 2
SI - Slovenia 2
TW - Taiwan 2
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
HU - Ungheria 1
IS - Islanda 1
MA - Marocco 1
RO - Romania 1
SM - San Marino 1
TH - Thailandia 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 9.672
Città #
Fairfield 974
Woodbridge 791
Jacksonville 555
Warsaw 505
Houston 498
Ashburn 411
Wilmington 375
Cambridge 363
Seattle 357
Ann Arbor 305
Princeton 221
Nanjing 217
Chandler 208
Hong Kong 204
Beijing 135
Dublin 118
Brescia 106
New York 105
Helsinki 74
Nanchang 72
Singapore 66
Hebei 55
San Diego 45
Dearborn 44
Des Moines 41
Changsha 39
Shenyang 38
Jinan 37
Tianjin 37
Shanghai 34
Milan 29
Jiaxing 26
Dong Ket 22
Kunming 22
Hangzhou 21
Verona 20
Brussels 19
San Francisco 16
San Mateo 16
Ningbo 15
Augusta 14
Boardman 14
Lanzhou 14
Toronto 14
Ardabil 13
Haikou 10
Leawood 10
Zhengzhou 10
Guangzhou 9
London 9
Los Angeles 8
Mumbai 8
Norwalk 8
Monmouth Junction 7
Auburn Hills 6
Taizhou 6
Lancaster 5
Taiyuan 5
Ancona 4
Ciudad Nezahualcoyotl 4
Como 4
Kilburn 4
Kocaeli 4
Munich 4
Nürnberg 4
Phoenix 4
Rome 4
Salina Cruz 4
Venezia 4
Washington 4
Bangalore 3
Brno 3
Canberra 3
Castelraimondo 3
Changchun 3
Fuzhou 3
Olomouc 3
Palermo 3
Redwood City 3
Shaoxing 3
Vicenza 3
Bologna 2
Castelnuovo 2
Cavallino 2
Chiswick 2
Hounslow 2
Indiana 2
Lappeenranta 2
Mantova 2
Minsk 2
Montichiari 2
New Bedfont 2
Pune 2
Redmond 2
Riga 2
Sabbio Chiese 2
Seoul 2
Taipei 2
Takamatsu 2
Tirano 2
Totale 7.525
Nome #
Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease. 258
Gene expression profile in fibroblasts of Huntington's disease patients and controls 211
Behavioral disorders in Alzheimer disease: a transcultural perspective 208
Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors. 202
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 162
Social networks and health status in the elderly: the ‘ANZIANI IN-RETE’ population-based study 160
The Italian version of the pain assessment in advanced dementia (PAINAD) scale 150
Gene expression profile in fibroblasts of Huntington's disease patients and controls. 144
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 144
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 142
Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study. 141
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 141
COVID-19 impact on consecutive neurological patients admitted to the emergency department 141
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 130
Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer’s Disease: A Case Control Study 122
Alzheimer disease and frontotemporal dementia. 118
Predictors of progression from mild cognitive impairment to Alzheimer disease. 117
Procedural memory stimulation in Alzheimer's disease: impact of a training programme. 116
Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD 116
Gene expression profile in fibroblasts of Huntington's disease patients and controls 116
A case report: doctor, my daughter has Alzheimer's disease. 114
Odor identification deficit predicts clinical conversion from mild cognitive impairment to dementia due to Alzheimer's disease. 112
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 110
Acetylcholinesterase inhibitors and depressive symptoms in patients with mild to moderate Alzheimer's disease. 109
Impaired financial abilities in mild cognitive impairment: a direct assessment approach. 108
Cognitive dysfunction and age-related macular degeneration. 106
Antihypertensive medications influence the rate of conversion from mild cognitive impairment to Alzheimer disease. 104
Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms. 103
Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. 102
Do vascular risk factors play a role in the progression of mild cognitive impairment? 102
Anxiety symptoms in mild cognitive impairment. 100
Differential Impact of Apathy and Depression in the Development of Dementia in Mild Cognitive Impairment Patients 100
Does reversible MCI exist? 100
Validity of direct assessment of functional status as a tool for measuring Alzheimer's disease severity. 100
Depressive disorders in dementia. 100
Diagnosis disclosure and advance care planning in Alzheimer disease: opinions of a sample of Italian citizens. 99
Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment. 98
Non-amnestic mild cognitive impairment and sleep complaints: a bidirectional relationship? 97
Behavioral syndromes in Alzheimer's disease: description and correlates. 96
Does age at observation time affect the clinical presentation of mild cognitive impairment? 96
The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease. 92
Object and action naming in Alzheimer's disease and frontotemporal dementia 92
Microvascular damage and platelet abnormalities in early Alzheimer's disease. 92
Differential Impact of Apathy and Depression in the Development of Dementia in Mild Cognitive Impairment Patients 92
Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy. 91
Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study 90
Free copper in serum: An analytical challenge and its possible applications 90
Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale. 89
Serum albumin level interferes with the effect of donepezil in Alzheimer's disease. 88
The migraine-PFO connection is independent of sex. 88
Pre-stroke and post-stroke dementia: Preliminary data from an Italian study 88
Transient global amnesia and venous flow patterns. 87
Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. 87
Severe worsening of parkinsonism in Lewy body dementia due to donepezil. 87
Surface dyslexia in an Italian patient with semantic dementia 87
The Italian Version of the Five-Word Test: A Simple Diagnostic Test for Dementia due to Alzheimer's Disease in Routine Clinical Practice 86
Prestroke dementia: characteristics and clinical features in consecutive series of patients. 85
Incidence of and risk factors for hallucinations and delusions in patients with probable AD. 84
Prevalence and demographic features of early-onset neurodegenerative dementia in Brescia County, Italy. 84
Transient global amnesia and disturbance of venous flow patterns 84
Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study. 84
Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors. 83
Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment 83
Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment. 82
Parkinsonian signs in subjects with mild cognitive impairment 79
Serum albumin level interferes with the effect of donepezil in Alzheimer's disease 79
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 79
Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration. 78
Transient global amnesia: a clinical and sonographic study 78
How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. 78
The impact of cognitive deficit on self-reported car crashes in ultra-octogenarian population: data of an Italian population-based study. 76
Spatial navigation in elderly healthy subjects, amnestic and non amnestic MCI patients 76
Depression is unrelated to conversion to dementia in patients with mild cognitive impairment. 75
Predictors of institutionalization in demented patients discharged from a rehabilitation unit 71
Results of a multi-level therapeutic approach for Alzheimer's disease subjects in the "real world" (CRONOS project): a 36-week follow-up study 70
Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study. 64
Changes in characteristics of Alzheimer patients at first visit to centers for dementia: a 10-year follow-up study. 63
Volume reduction in cerebral blood flow in patients with Alzheimer’s disease. A sonographic study 62
Acetylcholinestfrase inhibitors are effective in "real world" patients with mild to moderate Alzheimer disease: Evidence from a large population treated with rivastigmine or donepezil 60
Alteration of APP processing in platelets and CSF of AD patients European 60
Assessment of platelet Amyloid Precursor Protein forms ratio in patients with mild cognitive impairment: A tool for the identification of preclinical Alzheimer Disease 60
Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment. 59
App isoforms ratio in platelets: A peripheral marker for the diagnosis and treatment of Alzheimer's disease? 58
Apolipoprotein E allele and platelets amyloid precursor protein in Alzheimer's disease: Biological effect of acetylcholinesterase inhibitors treatment 54
Efficacy of SSRI on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors 53
Knowledge and attitudes about Alzheimer's disease in the lay public: influence of caregiving experience and other socio-demographic factors in an Italian sample. 52
Retrograde jugular venous flow is a predisposing factor in transient global amnesia. 51
Vascular risk factors for VaD and AD in a population-based prospective cohort. The PAQUID study 50
Platelet Amyloid Precursor Protein ratio as a biochemical marker for Alzheimer disease: Sensitivity and specificity 50
Clinical correlates of executive dysfunctions in mild cognitive impairment 50
Aspetti etici delle demenze 49
Hypercholesterolaemia increases platelet amyloid precusor protein processing impairment in Alzheimer's disease patients 49
Platelet Amyloid Precursor Protein ratio as a biochemical marker for Alzheimer disease: Sensitivity and specificity 48
Rehabilitation units for people suffering dementia. Reports on the development process for providing a model of care 47
Il progetto Cronos e le Unità di Valutazione Alzheime 46
Predictors of recurence in paradoxical cerebral embolism 45
Microvascular damage and platelet abnormalities in early Alzheimer's diseases 44
High donepezil doses and Parkinsonism symptoms: Case report 44
Short-term memory binding in mild cognitive impairment: a preclinical marker of Alzheimer's disease? 43
Differences in detecting symptoms of osteoarthritis in patients with cognitive impairment in two geriatric settings 43
Totale 9.333
Categoria #
all - tutte 40.883
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.883


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.034 455 108 124 388 194 318 282 336 206 328 132 163
2020/20211.987 47 275 81 192 129 242 76 250 210 172 242 71
2021/2022859 39 198 9 39 7 36 53 56 50 101 55 216
2022/2023691 129 21 12 35 65 207 6 61 91 4 25 35
2023/2024740 48 25 73 43 21 123 29 26 213 13 9 117
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 9.841